drugset
drugset / Trial / NCT03381586

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

NCT03381586 ↗

Phase 1 Completed 20 enrolled Altor BioScience
RandomizedParallel-groupOpen-labelBasic science

Summary

This is a single center, open-label, pharmacokinetic study of ALT-803 administered as a subQ injection to healthy volunteers.

Timeline

Start
2017-12-27
Primary completion
2018-03-13
Completion
2018-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject N-803 Protein / enzyme biologic 10 ug/kg Subcutaneous
Subject N-803 Protein / enzyme biologic 20 ug/kg Subcutaneous

Indications

No indication recorded.